Nicholson Nur, Chief Technical Officer of Apellis Pharmaceuticals ($APLS), sold common shares on the open market three times in the last 365 days for a total of about $270,000. His most recent sale occurred on January 22, 2026. These $APLS insider sales rank 7,795th among 11,678 individual insiders, well below the average sale amount of 8.6 million and average of 6.37 transactions. Nicholson Nur recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Common Stock | 45220 | $0.00 | 116,338.0000 | 130,067,000 | 63.58% | 0.03% |
| Jan. 22, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 7725 | $21.77 | 71,118.0000 | 130,067,000 | 9.80% | 0.01% |
| Jan. 20, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2203 | $19.79 | 78,843.0000 | 130,067,000 | 2.72% | 0.00% |
| Jan. 13, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2618 | $22.19 | 81,046.0000 | 130,067,000 | 3.13% | 0.00% |
| June 9, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| Jan. 29, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 825 | $29.52 | 83,664.0000 | 123,905,000 | 0.98% | 0.00% |
| Jan. 22, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 3948 | $30.43 | 84,489.0000 | 123,905,000 | 4.46% | 0.00% |
| Jan. 21, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Common Stock | 36426 | $0.00 | 88,437.0000 | 123,905,000 | 70.04% | 0.03% |
| Jan. 17, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2145 | $29.96 | 52,011.0000 | 123,905,000 | 3.96% | 0.00% |
| Jan. 13, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2632 | $28.70 | 54,156.0000 | 123,905,000 | 4.63% | 0.00% |
| March 13, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 3452 | $58.13 | 56,287.0000 | 118,678,000 | 5.78% | 0.00% |
| March 13, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 7768 | $57.31 | 59,739.0000 | 118,678,000 | 11.51% | 0.01% |
| Jan. 29, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 835 | $64.14 | 67,507.0000 | 118,678,000 | 1.22% | 0.00% |
| Jan. 22, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2593 | $65.00 | 68,342.0000 | 118,678,000 | 3.66% | 0.00% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Common Stock | 19508 | $0.00 | 72,792.0000 | 118,678,000 | 36.61% | 0.02% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 1857 | $66.81 | 70,935.0000 | 118,678,000 | 2.55% | 0.00% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 28367 | $66.30 | 28,367.0000 | 118,678,000 | 9999.99% | 0.02% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 9719 | $42.21 | 63,915.0000 | 106,114,000 | 13.20% | 0.01% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | S | Common Stock | 10631 | $46.15 | 53,284.0000 | 106,114,000 | 16.63% | 0.01% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | M | Stock Option (Right to Buy) | 9719 | $0.00 | 115,281.0000 | 106,114,000 | 7.78% | 0.01% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | M | Common Stock | 9719 | $29.76 | 73,634.0000 | 106,114,000 | 15.21% | 0.01% |
| Feb. 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Common Stock | 9886 | $0.00 | 64,328.0000 | 106,114,000 | 18.16% | 0.01% |
| Feb. 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | F | Common Stock | 825 | $58.50 | 63,503.0000 | 106,114,000 | 1.28% | 0.00% |
| Feb. 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 27, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | F | Common Stock | 551 | $52.77 | 54,442.0000 | 106,114,000 | 1.00% | 0.00% |
| Jan. 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | F | Common Stock | 2034 | $52.05 | 54,993.0000 | 106,114,000 | 3.57% | 0.00% |
| April 25, 2022 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | J | Stock Option (Right to Buy) | 11250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 35472 | $52.66 | 35,472.0000 | 106,114,000 | 9999.99% | 0.03% |
| Jan. 12, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | A | Common Stock | 22580 | $0.00 | 57,027.0000 | 106,114,000 | 65.55% | 0.02% |
| April 25, 2022 | Apellis Pharmaceuticals, Inc. | $APLS | Nicholson Nur | Chief Technical Officer | J | Common Stock | 1875 | $0.00 | 33,680.0000 | 0 | 5.27% | 0.00% |